iShares U.S. Healthcare ETF News - July 10, 2026

Ionis and AstraZeneca Fail Phase 3, Stalling Lucrative Eplontersen Expansion

Ionis Pharmaceuticals (Nasdaq: IONS) and AstraZeneca announced today that their Phase 3 CARDIO-TTRansform trial for eplontersen failed its primary endpoint....